Streetbeat News

Price Targets

PG

DZ Bank analyst Michael Pohn has upgraded Procter & Gamble (NYSE:PG) from Sell to Hold and announced a price target of $155.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 5:19 pm

ROL

Stifel analyst Michael Hoffman has upgraded Rollins (NYSE:ROL) from Hold to Buy and announced a $40 price target.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 5:16 pm

CW

Truist Securities analyst Michael Ciarmoli has reiterated a 'Buy' rating on Curtiss-Wright (NYSE:CW) and maintained a price target of $215.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 5:11 pm

WTFC

Truist Securities analyst Brandon King maintains a 'Buy' rating on Wintrust Finl (NASDAQ:WTFC) and raises the price target from $86 to $92.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 5:03 pm

SPCE

Truist Securities analyst Michael Ciarmoli has maintained a 'Sell' rating on Virgin Galactic Holdings (NYSE:SPCE) and lowered the price target from $3 to $1.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 5:01 pm

LBRT

Liberty Energy (NYSE:LBRT) has received 2 somewhat bullish and 3 indifferent analyst ratings in the last quarter. The company's average 12-month price target has increased by 17.02% from the previous average, now standing at $22.0 with a high of $27.00 and a low of $18.00.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 5:00 pm

CYTK

HC Wainwright & Co. has maintained its Buy rating for Cytokinetics (NASDAQ:CYTK) and raised its price target from $49.00 to $58.00. This new target price represents a 73.24% increase from the current share price. Cytokinetics is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 5:00 pm

SPR

Truist Securities analyst Michael Ciarmoli has maintained a 'Hold' rating on Spirit AeroSystems Hldgs (NYSE:SPR) and lowered the price target from $25 to $20.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 5:00 pm

MAN

Truist Securities analyst Tobey Sommer has maintained a 'Hold' rating on ManpowerGroup (NYSE:MAN) and lowered the price target from $80 to $75.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 4:58 pm

LHX

Truist Securities analyst Michael Ciarmoli maintains a 'Buy' rating on L3Harris Technologies (NYSE:LHX) but has lowered the price target from $255 to $227.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 4:56 pm